# Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL

> **NCT04863742** · PHASE4 · UNKNOWN · sponsor: **Sight Medical Doctors PLLC** · enrollment: 30 (estimated)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** Dextenza 0.4Mg Ophthalmic Insert
- **DRUG:** Prednisolone Acetate

## Key facts

- **NCT ID:** NCT04863742
- **Lead sponsor:** Sight Medical Doctors PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-26
- **Primary completion:** 2021-07-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863742, "Evaluation Of Vision Recovery And Comfort Index In Patients With Borderline/Mild Dry Eyes Undergoing FLACS With Premium IOL". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04863742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*